Latest News
Aiforia deal to expand access to pathology AI
October 22, 2026AI, Corporate, Devices, Hospital Management, commercial agreements, digital pathology
Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to …
SMC accepts atogepant for acute migraine treatment in Scotland
October 22, 2026Neurology, SMC, clinical trial, migraine
The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of migraine with …
Claris reports visual acuity gains with experimental LSCD treatment
October 21, 2026Opthalmology, cytology, ophthalmics
Claris Biotherapeutics has reported visual acuity improvements with its experimental therapy CSB-001 in a proof-of-concept study involving patients with limbal …
Amphista doses first patient in AML trial of protein degrader
October 20, 2026AML, FDA, Oncology, clinical trial, drug development, pharma
Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an experimental oral therapy targeting acute …
First 90 days of antipsychotic treatment linked to rapid metabolic changes
October 20, 2026Diabetes, NIHR, Psychiatry, UCL, antipsychotic drugs, diabetes, mental health, mental illness
The first 90 days after starting antipsychotic treatment are a critical period for monitoring blood glucose and weight, according to …
Digital platform cuts pharmaceutical quality-record approval times by up to 90%
October 19, 2026Pharmacovigilance, Regulatory Affairs Devices, Hospital Management, certification, digitalisation, pharmaceutical, regulatory, supply chain
A digital platform for exchanging pharmaceutical quality records between supply-chain partners is now commercially available, following an Innovate UK-funded project …
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026ADCs, Corporate, HPLC, Immunology, Infections and infestations, Oncology, manufacturing
Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing capacity and …
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026Devices, Diagnostics, Hospital Management, Oncology, laser imaging, lung disease, tumour
Femtosecond laser imaging has reduced the time needed to assess lung tumour margins from 36 minutes to less than six …
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026Diagnostics, Haematology, Neurological Diseases, Neurology, Parkinson's disease, blood testing, sleep disorder
Researchers at King Abdullah University of Science and Technology (KAUST) and the University of Oxford have developed a blood-based electronic …
Cori Clinical raises US$4m to expand AI platform for clinical trial design
October 14, 2026AI, Data Capture, Pharmacy, clinical data, clinical trial design, regulatory affairs
Cori Clinical has raised US$4m in a seed funding round to expand its AI platform for clinical trial design and …
Ofichem acquires US drug substance CDMO Kinentia
October 14, 2026Biotechnology, CDMO, Pharmacy, acquisitions, drug substance development
Ofichem has agreed to acquire Kinentia Biosciences, a US drug substance contract development and manufacturing organisation (CDMO), in a deal …
Tridem begins phase Ib trial of Parkinson’s disease vaccine
October 13, 2026Cardiology, Neurology, Parkinson's disease, Vaccine, clinical trial
Tridem Bioscience has enrolled the first patients in a phase Ib clinical trial of TRB-001, an intradermal therapeutic vaccine targeting …
Bio-Techne opens GMP small-molecule manufacturing facility in Bristol
October 13, 2026Cardiology, Cleanroom, Diabetes, Haematology, Neurology, Rare Diseases, cell therapies, manufacturing and production, small molecules
Bio-Techne has opened a new facility in Bristol manufacturing Good Manufacturing Practice (GMP)-grade small molecules for cell therapy developers. The …
UK immunoglobulin supply faces growing pressure, report warns
October 12, 2026Manufacturing and Production Critical supplies, Immunology, NHS Blood and Transplant, Neurology, procurement
The UK may face increasing pressure to secure long-term supplies of immunoglobulin (Ig), with rising demand and heavy reliance on …
NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma
October 8, 2026NICE, Oncology, drug recommendation, drug regulation
NICE has published final draft guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone (D-VRd) for previously untreated adults with multiple …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
The evidence bar impacting UK medical cannabis access
